Casimiro M.; Di Sante G.; Ju X.; Li Z.; Chen K.; Crosariol M.; Yaman I.; Gormley M.; Meng H.; Lisanti M.; Pestell R.
(2016)
© 2016 American Association for Cancer Research.Therapy resistance and poor outcome in prostate cancer is associated with increased expression of cyclin D1. Androgens promoteDNAdouble-strand break repair to reduceDNAdamage, ...